Objective In this study,we aimed to investigate the combined effect of Trastuzumab plus recombinant human Endostatin(rh-endostatin)on SK-BR3 breast carcinoma cells in vivo,and its underlying mechanism
Objective Indoleamin-2,3-dioxygenase-1(IDO1),has been identified as a checkpoint protein involved in generating the immunosuppressive tumor microenvironment that supports tumor growth.
Objective Chronic inflammation might lead to many malignancies,and inadequate resolution could play a crucial role in tumor invasion,progression and metastases.